Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mental Health International is a small Canada-based mental health organization focused on mental health, addiction, brain health, and workplace well-being education rather than drug development. Public descriptions indicate it was founded in 2013 as the successor to the Global Business and Economic Roundtable on Addiction and Mental Health, and it operates primarily as a resource, thought-leadership, and advisory platform. Its activities appear to center on publishing analyses, maintaining an information library, and supporting dialogue on mental disorders, business, and economic impacts of brain-based conditions. The organization does not appear to have a therapeutic drug pipeline, clinical-stage assets, or proprietary biopharmaceutical programs. For biotech analyst purposes, it is best categorized as a health-focused nonprofit/services entity rather than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mental Health International.